No Data
No Data
No Data
No Data
No Data
Precipio Inc Schedules Year-End Shareholder Update Call
TipRanksMar 26 16:53 ET
Precipio Announces Year End 2023 Shareholder Update Call
NEW HAVEN, Conn., March 25, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), will be hosting its year end 2023 corporate update call on April 1st, 2024 at 5:00 PM ET. The call
GlobeNewswireMar 25 17:00 ET
Precipio to Report $15.2M for FY-2023 (Unaudited) Revenues, an Increase of 60% YoY
NEW HAVEN, Conn., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), announces that for the full year of 2023, its unaudited revenues have grown from $9.4M in 2022 to
GlobeNewswireFeb 13 10:00 ET
Express News | Precipio Shares Halted On Circuit Breaker To The Upside, Stock Now Up 6.46%
Moomoo 24/7Feb 6 10:04 ET
Precipio and Cardinal Health Sign Distribution Agreement for Its HemeScreen Portfolio of Molecular Assays for Cancer
NEW HAVEN, Conn., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) announces it has entered into a distribution agreement with Cardinal Health for its HemeScreen
GlobeNewswireFeb 6 10:00 ET
Press Release: Precipio's Q4-2023 Cash Burn From Operations (Unaudited) Drops Below $100K for the Full Quarter
Precipio's Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarter Results clearly demonstrate the business's ability to reach breakeven in the near future NEW HAVEN, Co
Dow JonesJan 23 10:00 ET
No Data
No Data